These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 1618904)
1. Chondrodysplasia in transgenic mice harboring a 15-amino acid deletion in the triple helical domain of pro alpha 1(II) collagen chain. Metsäranta M; Garofalo S; Decker G; Rintala M; de Crombrugghe B; Vuorio E J Cell Biol; 1992 Jul; 118(1):203-12. PubMed ID: 1618904 [TBL] [Abstract][Full Text] [Related]
2. Reduced amounts of cartilage collagen fibrils and growth plate anomalies in transgenic mice harboring a glycine-to-cysteine mutation in the mouse type II procollagen alpha 1-chain gene. Garofalo S; Vuorio E; Metsaranta M; Rosati R; Toman D; Vaughan J; Lozano G; Mayne R; Ellard J; Horton W Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9648-52. PubMed ID: 1946380 [TBL] [Abstract][Full Text] [Related]
3. Impact of mutations of cartilage matrix genes on matrix structure, gene activity and chondrogenesis. So CL; Kaluarachchi K; Tam PP; Cheah KS Osteoarthritis Cartilage; 2001; 9 Suppl A():S160-73. PubMed ID: 11680681 [TBL] [Abstract][Full Text] [Related]
4. Depletion of cartilage collagen fibrils in mice carrying a dominant negative Col2a1 transgene affects chondrocyte differentiation. Barbieri O; Astigiano S; Morini M; Tavella S; Schito A; Corsi A; Di Martino D; Bianco P; Cancedda R; Garofalo S Am J Physiol Cell Physiol; 2003 Dec; 285(6):C1504-12. PubMed ID: 12917109 [TBL] [Abstract][Full Text] [Related]
5. Targeted disruption of Col11a2 produces a mild cartilage phenotype in transgenic mice: comparison with the human disorder otospondylomegaepiphyseal dysplasia (OSMED). Li SW; Takanosu M; Arita M; Bao Y; Ren ZX; Maier A; Prockop DJ; Mayne R Dev Dyn; 2001 Oct; 222(2):141-52. PubMed ID: 11668593 [TBL] [Abstract][Full Text] [Related]
6. Abnormal craniofacial morphology and cartilage structure in transgenic mice harboring a Gly --> Cys mutation in the cartilage-specific type II collagen gene. Rintala M; Metsäranta M; Garofalo S; de Crombrugghe B; Vuorio E; Rönning O J Craniofac Genet Dev Biol; 1993; 13(3):137-46. PubMed ID: 8227287 [TBL] [Abstract][Full Text] [Related]
7. Skeletal abnormalities and ultrastructural changes of cartilage in transgenic mice expressing a collagen II gene (COL2A1) with a Cys for Arg-alpha1-519 substitution. Arita M; Li SW; Kopen G; Adachi E; Jimenez SA; Fertala A Osteoarthritis Cartilage; 2002 Oct; 10(10):808-15. PubMed ID: 12359167 [TBL] [Abstract][Full Text] [Related]
8. Retarded skeletal development in transgenic mice with a type II collagen mutation. Savontaus M; Metsranta M; Vuorio E Am J Pathol; 1996 Dec; 149(6):2169-82. PubMed ID: 8952549 [TBL] [Abstract][Full Text] [Related]
9. Spondylometaphyseal dysplasia in mice carrying a dominant negative mutation in a matrix protein specific for cartilage-to-bone transition. Jacenko O; LuValle PA; Olsen BR Nature; 1993 Sep; 365(6441):56-61. PubMed ID: 8361538 [TBL] [Abstract][Full Text] [Related]
10. In situ hybridization studies on the expression of type X collagen in fetal human cartilage. Reichenberger E; Aigner T; von der Mark K; Stöss H; Bertling W Dev Biol; 1991 Dec; 148(2):562-72. PubMed ID: 1743401 [TBL] [Abstract][Full Text] [Related]
11. Perlecan is essential for cartilage and cephalic development. Arikawa-Hirasawa E; Watanabe H; Takami H; Hassell JR; Yamada Y Nat Genet; 1999 Nov; 23(3):354-8. PubMed ID: 10545953 [TBL] [Abstract][Full Text] [Related]
12. Y-position collagen II mutation disrupts cartilage formation and skeletal development in a transgenic mouse model of spondyloepiphyseal dysplasia. Gaiser KG; Maddox BK; Bann JG; Boswell BA; Keene DR; Garofalo S; Horton WA J Bone Miner Res; 2002 Jan; 17(1):39-47. PubMed ID: 11771668 [TBL] [Abstract][Full Text] [Related]
13. Expression of type I, type II, and type X collagen genes during altered endochondral ossification in the femoral epiphysis of osteosclerotic (oc/oc) mice. Yamasaki A; Itabashi M; Sakai Y; Ito H; Ishiwari Y; Nagatsuka H; Nagai N Calcif Tissue Int; 2001 Jan; 68(1):53-60. PubMed ID: 12037624 [TBL] [Abstract][Full Text] [Related]
14. An inbred line of transgenic mice expressing an internally deleted gene for type II procollagen (COL2A1). Young mice have a variable phenotype of a chondrodysplasia and older mice have osteoarthritic changes in joints. Helminen HJ; Kiraly K; Pelttari A; Tammi MI; Vandenberg P; Pereira R; Dhulipala R; Khillan JS; Ala-Kokko L; Hume EL J Clin Invest; 1993 Aug; 92(2):582-95. PubMed ID: 8349798 [TBL] [Abstract][Full Text] [Related]
15. Mice lacking matrilin-1 (cartilage matrix protein) have alterations in type II collagen fibrillogenesis and fibril organization. Huang X; Birk DE; Goetinck PF Dev Dyn; 1999 Dec; 216(4-5):434-41. PubMed ID: 10633862 [TBL] [Abstract][Full Text] [Related]
16. A fibrillar collagen gene, Col11a1, is essential for skeletal morphogenesis. Li Y; Lacerda DA; Warman ML; Beier DR; Yoshioka H; Ninomiya Y; Oxford JT; Morris NP; Andrikopoulos K; Ramirez F Cell; 1995 Feb; 80(3):423-30. PubMed ID: 7859283 [TBL] [Abstract][Full Text] [Related]
17. Tracheomalacia in a neonate with kniest dysplasia: histopathologic and ultrastructural features. Hicks J; De Jong A; Barrish J; Zhu SH; Popek E Ultrastruct Pathol; 2001; 25(1):79-83. PubMed ID: 11297324 [TBL] [Abstract][Full Text] [Related]
18. A dominant interference collagen X mutation disrupts hypertrophic chondrocyte pericellular matrix and glycosaminoglycan and proteoglycan distribution in transgenic mice. Jacenko O; Chan D; Franklin A; Ito S; Underhill CB; Bateman JF; Campbell MR Am J Pathol; 2001 Dec; 159(6):2257-69. PubMed ID: 11733375 [TBL] [Abstract][Full Text] [Related]
19. Type II collagen pro-alpha-chains containing a Gly574Ser mutation are not incorporated into the cartilage matrix of transgenic mice. Maddox BK; Garofalo S; Keene DR; Smith C; Horton WA Matrix Biol; 1997 Aug; 16(3):93-103. PubMed ID: 9314159 [TBL] [Abstract][Full Text] [Related]
20. Retarded chondrogenesis in transgenic mice with a type II collagen defect results in fracture healing abnormalities. Hiltunen A; Metsäranta M; Virolainen P; Aro HT; Vuorio E Dev Dyn; 1994 Aug; 200(4):340-9. PubMed ID: 7994081 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]